Article

Authors’ Reply: The Cost of Hybrid Treatment for Atrial Fibrillation

Register or Login to View PDF Permissions
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
Average (ratings)
No ratings
Your rating
Copyright Statement:

The copyright in this work belongs to Radcliffe Medical Media. Only articles clearly marked with the CC BY-NC logo are published with the Creative Commons by Attribution Licence. The CC BY-NC option was not available for Radcliffe journals before 1 January 2019. Articles marked ‘Open Access’ but not marked ‘CC BY-NC’ are made freely accessible at the time of publication but are subject to standard copyright law regarding reproduction and distribution. Permission is required for reuse of this content.

Dear Sir,

The question referring to the financial costs of one-stage hybrid surgery for atrial fibrillation in countries where reimbursement is limited is relevant in our modern cost–benefit driven society. But your question is out of the context of our manuscript as we never alluded to the financial aspects of the technique.

Costs for one-stage hybrid atrial fibrillation surgery are important as several highly specialised teams are simultaneously involved and specific, quickly changing electrophysiological material is requested.

A financial contribution from the Belgian patient is currently requested for the epicardial ablation part of the procedure in Belgium. This is in contrast with the endocardial ablation part, which is in most cases covered by the patient’s own medical health Insurance.

The evaluation of costs for patients living abroad in Europe is a more complex, more individually and state-regulated matter and is calculated in agreement with our financial department.